Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Glycoprotein composition in cyclophosphamide-induced lung fibrosis.

Venkatesan N, Punithavathi D, Chandrakasan G.

Biochim Biophys Acta. 1998 Aug 14;1407(2):125-34.

2.

Biochemical and connective tissue changes in cyclophosphamide-induced lung fibrosis in rats.

Venkatesan N, Punithavathi D, Chandrakasan G.

Biochem Pharmacol. 1998 Oct 1;56(7):895-904.

PMID:
9774151
3.

Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats.

George J, Chandrakasan G.

Int J Biochem Cell Biol. 1996 Mar;28(3):353-61.

PMID:
8920645
4.

Proteinases and proteinase inhibitors during the development of pulmonary fibrosis in rat.

Koslowski R, Knoch KP, Wenzel KW.

Clin Chim Acta. 1998 Mar 9;271(1):45-56.

PMID:
9564556
5.

Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats.

Iraz M, Erdogan H, Kotuk M, Yağmurca M, Kilic T, Ermis H, Fadillioğlu E, Yildirim Z.

Pharmacol Res. 2006 Mar;53(3):310-6. Epub 2006 Feb 3.

PMID:
16459098
6.
8.

Cyclophosphamide Combined with Bone Marrow Mesenchymal Stromal Cells Protects against Bleomycin-induced Lung Fibrosis in Mice.

Xu J, Li L, Xiong J, Zheng Y, Ye Q, Li Y.

Ann Clin Lab Sci. 2015 Spring;45(3):292-300.

PMID:
26116593
9.

Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.

Kalayarasan S, Sriram N, Sudhandiran G.

Life Sci. 2008 Jun 6;82(23-24):1142-53. doi: 10.1016/j.lfs.2008.03.018. Epub 2008 Apr 4.

PMID:
18462759
10.

Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.

Egger C, Gérard C, Vidotto N, Accart N, Cannet C, Dunbar A, Tigani B, Piaia A, Jarai G, Jarman E, Schmid HA, Beckmann N.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15;306(12):L1064-77. doi: 10.1152/ajplung.00027.2014. Epub 2014 Apr 11.

11.

Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.

Cai Y, Kimura S.

PLoS One. 2015 Nov 11;10(11):e0142497. doi: 10.1371/journal.pone.0142497. eCollection 2015.

12.

Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.

Venkatesan N, Tsuchiya K, Kolb M, Farkas L, Bourhim M, Ouzzine M, Ludwig MS.

Am J Respir Cell Mol Biol. 2014 Mar;50(3):583-94. doi: 10.1165/rcmb.2012-0226OC.

PMID:
24127863
13.

[Increased expression of placenta growth factor in lung tissue of paraquat-induced rat pulmonary fibrosis model].

Zheng MH, Dai MS, Lin LF.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2007 Sep;25(9):527-31. Chinese.

PMID:
17997886
14.

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Zhu Y, Liu Y, Zhou W, Xiang R, Jiang L, Huang K, Xiao Y, Guo Z, Gao J.

Respir Res. 2010 Mar 20;11:34. doi: 10.1186/1465-9921-11-34.

15.

Increased pulmonary collagen synthesis in mice treated with cyclophosphamide.

Lee YC, Kehrer JP.

Drug Chem Toxicol. 1985;8(6):503-12.

PMID:
4092621
16.

siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.

Zhang YP, Li WB, Wang WL, Liu J, Song SX, Bai LL, Hu YY, Yuan YD, Zhang M.

Acta Pharmacol Sin. 2012 Jul;33(7):897-908. doi: 10.1038/aps.2012.39. Epub 2012 Jun 4.

17.
18.

Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats.

Yildirim Z, Kotuk M, Erdogan H, Iraz M, Yagmurca M, Kuku I, Fadillioglu E.

J Pineal Res. 2006 Jan;40(1):27-33.

PMID:
16313495
19.

Agmatine attenuates silica-induced pulmonary fibrosis.

El-Agamy DS, Sharawy MH, Ammar EM.

Hum Exp Toxicol. 2014 Jun;33(6):650-60. doi: 10.1177/0960327114521047. Epub 2014 Feb 6.

PMID:
24505053
20.

Supplemental Content

Support Center